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ABSTRACT
Objective Adherent-invasive Escherichia coli (AIEC) are
a leading candidate bacterial trigger for Crohn’s disease
(CD). The AIEC pathovar is deﬁned by in vitro cell-line
assays examining speciﬁc bacteria/cell interactions. No
molecular marker exists for their identiﬁcation. Our aim
was to identify a molecular property common to the
AIEC phenotype.
Design 41 B2 phylogroup E. coli strains were isolated
from 36 Australian subjects: 19 patients with IBD and
17 without. Adherence/invasion assays were conducted
using the I-407 epithelial cell line and survival/replication
assays using the THP-1 macrophage cell line. Cytokine
secretion tumour necrosis factor ((TNF)-α, interleukin (IL)
6, IL-8 and IL-10) was measured using ELISA. The
genomes were assembled and annotated, and cluster
analysis performed using CD-HIT. The resulting matrices
were analysed to identify genes unique/more frequent in
AIEC strains compared with non-AIEC strains. Base
composition differences and clustered regularly
interspaced palindromic repeat (CRISPR) analyses were
conducted.
Results Of all B2 phylogroup strains assessed, 79%
could survive and replicate in macrophages. Among
them, 11/41 strains (5 CD, 2 UCs, 5 non-IBD) also
adhere to and invade epithelial cells, a phenotype
assigning them to the AIEC pathovar. The AIEC strains
were phylogenetically heterogeneous. We did not identify
a gene (or nucleic acid base composition differences)
common to all, or the majority of, AIEC. Cytokine
secretion and CRISPRs were not associated with the
AIEC phenotype.
Conclusions Comparative genomic analysis of AIEC
and non-AIEC strains did not identify a molecular
property exclusive to the AIEC phenotype. We
recommend a broader approach to the identiﬁcation of
the bacteria-host interactions that are important in the
pathogenesis of Crohn’s disease.
INTRODUCTION
Crohn’s disease (CD) is a complex disease that is
thought to result from interactions between luminal
microbes and the host innate immune system, in
genetically susceptible individuals.1 The number of
host susceptibility loci identiﬁed for the IBDs con-
tinues to grow: over 200 have now been identiﬁed,
30 of which are CD-speciﬁc.2 3 The most signiﬁ-
cant, replicable host mutations encode genes
involved in the detection of, signalling in response
to and clearance of, bacteria. The gut microbiome is
altered in patients with CD relative to controls:4–8
studies show an increase in mucosa-associated
Escherichia coli in both ileum and colon,4 9–14 but
no single causative micro-organism has been
identiﬁed.
The adherent-invasive E. coli (AIEC) pathovar
was ﬁrst described by Boudeau et al15 in 1999, and
has emerged as a leading candidate bacterial trigger
for CD. E. coli belonging to this pathovar are
deﬁned by their in vitro abilities to adhere to and
to invade epithelial cells, and to survive and repli-
cate within macrophages.9 16 17
E. coli is a phylogenetically diverse species, and
strains are often assigned one of eight major phy-
logroups (A, B1, B2, C, D, E, F and Escherichia
Cryptic Clade i) by PCR.18 Approximately 47% of
strains isolated from human mucosal biopsies are
phylogroup B2, which, when present in a host, are
likely to be the dominant strain.19 The majority
Signiﬁcance of this study
What is already known on this subject?
▸ Identifying the functional and/or genetic
properties of bacterial triggers of Crohn’s
disease may lead to effective therapeutic
strategies.
▸ Adherent-invasive Escherichia coli (AIEC) are
more commonly isolated from mucosal biopsies
of patients with Crohn’s disease than controls.
▸ AIEC are deﬁned by their phenotype: the
ability, in vitro, to adhere to and invade
epithelial cell lines and survive and replicate
within macrophages.
▸ To date, no virulence factor, gene or
combination of genes, has been found to
explain the AIEC phenotype.
What are the new ﬁndings?
▸ Whole-genome sequencing could not deﬁne a
speciﬁc genotype that explains the AIEC
phenotype.
▸ Survival and replication within macrophages is
a common feature of E. coli isolated from
intestinal mucosa generally.
How might it impact on clinical practice in
the foreseeable future?
▸ Beyond AIEC, other aspects of the
host-microbiome interaction should be
examined.
O’Brien CL, et al. Gut 2016;0:1–8. doi:10.1136/gutjnl-2015-311059 1
Gut microbiota
 Gut Online First, published on May 19, 2016 as 10.1136/gutjnl-2015-311059
Copyright Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& BSG) under licence. 
group.bmj.com on October 10, 2016 - Published by http://gut.bmj.com/Downloaded from 
(64%) of AIEC isolates belong to the B2 phylogroup,12 and this
phylogroup typically contains more virulence factors than
strains belonging to other phylogroups.20 Multilocus sequence
typing (MLST) is also used to assign E. coli into sequence types
(STs), using one of three schemes.21–23 Any mucosa-associated
strain, regardless of phylogroup, is likely to be found along the
length of the lower GI tract, and is unlikely to be restricted to a
single region.19 ST95 strains are commonly isolated from
humans and belong to the B2 phylogroup.24
AIEC are more commonly isolated from mucosal biopsies of
patients with CD (36–52%) than controls (6–17%),9 12 and one
study showed that only 6.3% of extraintestinal pathogenic E.
coli (ExPEC) strains were AIEC.25 As observed for other patho-
gens, such as uropathogenic E. coli (UPEC), different mechan-
isms are involved in the colonisation of the epithelium by AIEC.
For example, it is thought that AIEC colonise the ileal mucosa
in patients with CD through abnormal expression of carcinoem-
bryonic antigen-related cell adhesion molecule 6 (CEACAM6)
receptors recognising type 1 pili.26 27 Point mutations in the
FimH adhesion of AIEC result in an increased ability to adhere
to CEACAM6-expressing intestinal epithelial cells.28 AIEC also
target M cells on Peyer’s patches through the expression of type
1 pili and long polar ﬁmbriae (LPF), a mechanism allowing
them to translocate across the intestinal epithelial barrier.
Several studies have attempted to identify virulence factors
associated with the AIEC phenotype. Conte et al17 showed that
some virulence genes are more frequent in the E. coli isolates
from patients with CD than controls, including: K1 and kpsMT
II, both involved in capsule synthesis; fyuA, involved in iron
acquisition; and ibeA, involved in invasion. The relative abun-
dance of these strains was signiﬁcantly higher in patients with
CD (10%) compared with controls (1%). Comparative genome
sequencing conducted by Dogan et al29 on isolates from differ-
ent origins (patients with CD, dogs with granulomatous colitis
and mouse ileitis) failed to detect a molecular property asso-
ciated with the AIEC phenotype. However, their study revealed
that certain factors were associated with CD-derived AIEC,
including pduC (a putative glycerol dehydatase) and chuA,
(involved in haem acquisition), which is present in all B2 strains
of E. coli. CD-associated AIEC harbouring lpfA (involved in cell
attachment) displayed a high level of invasion of epithelial cells
and translocation through M cells. Desilets et al30 conducted
comparative genome analyses on a panel of E. coli strains, con-
taining 14 IBD-associated strains that were only assessed for
their ability to replicate intracellularly in the RAW264.7 macro-
phage cell line, and 40 published genomes comprising various
pathovars of E. coli including AIEC. They did not identify a
gene in common to all AIEC/IBD-associated E. coli strains, but
suggested that B2 phylogroup AIEC may represent a distinct
cluster of IBD-associated E. coli. Recently, Deshpande et al31
conducted a genome comparison of four AIEC and ﬁve other E.
coli strains belonging to the UPEC, ExPEC and Avian patho-
genic Escherichia coli (APEC) pathovars. They identiﬁed six
amino acid changes associated with all nine strains, then used
these amino acid changes to scan a large set of E. coli strains.
Of the 1311 strains, 73 clustered with the 9 original strains.
Because seven of these were ST95, the majority of strains that
clustered with the AIEC strains were also ST95. It is likely that
the associations they describe are phylogenetic in nature and do
not reﬂect the pathogenic potential of the strains.
Currently, the only way to identify AIEC strains is by con-
ducting bacteria/cell interaction assays. Although several molecu-
lar markers have been associated with AIEC and/or play a role
in AIEC virulence, they are not present in all AIEC strains and
cannot be used to deﬁne the pathovar. The aim of this study
was to compare human-derived AIEC and non-AIEC strains
with similar genetic backgrounds (B2 phylogroup and ST95
lineage), isolated from the same site in the intestine, using
whole-genome sequencing and other methods to identify a
molecular marker of the AIEC phenotype.
MATERIALS AND METHODS
Bacterial isolates
All patients and controls attended Canberra Hospital, Australia,
and gave their informed consent. Ethics approval was obtained
from the hospital and university ethics committees. We preferen-
tially selected genetically similar E. coli strains by focusing on
the B2 phylogroup, ST95 strains, isolated from a single host
species (human) and gut region (terminal ileum). This was done
to eliminate among-strain variation, and to account for the pos-
sibility that AIEC has host-species or gut-region preferences.
Strain LF82, isolated from a patient with ileal CD, is the arche-
typal AIEC strain,32 belongs to the B2 phylogroup of E. coli and
was used as a positive control. Strain K12 does not display the
AIEC phenotype and was used in the in vitro assays only, as a
negative control. Strain ED1a was included because it was iso-
lated from a healthy control, belongs to the B2 phylogroup and
was found to be avirulent in a mouse lethality model.33 The 41
strains in this study were isolated from 36 Australian patients
with and without IBD (14 CD; 5 UC; 21 non-IBD), as described
in Gordon et al;34 O’Brien et al;7 and Gordon et al.35 Strain
characteristics can be found in online supplementary material. All
strains and tissues were stored at −80°C in luria broth (LB) gly-
cerol until required. The serotype of each strain was determined
using the Center for Genomic Epidemiology’s online SeroType
Finder tool (http://www.genomicepidemiology.org).36 The ST
was determined using the MLST methods of Wirth et al.23 The
E. coli phylogroup was determined for each strain using a quad-
ruplex PCR described by Clermont et al,18 which assigns B2
strains (and other phylogroups) based on the presence/absence of
four genes (chuA, yjaA, TspE4.C2 and ArpA).
Phenotypical assays
We assessed the ability of all strains to adhere to and invade intes-
tinal epithelial cell lines, as well as survive and replicate within
macrophage cell lines, by conducting gentamicin protection
assays with intestine-407 epithelial cells (American Type Culture
Collection (ATCC) chemokine [c-c motif ] ligand 6 (CCL-6)) and
THP-1 macrophages (ATCC TIB-202), respectively, as previously
described. We followed the methods of Darfeuille-Michaud
et al,9 except that we used the human-derived THP-1 cell line
instead of the murine J774 cell line. Assays were performed in
24-well tissue culture plates, in triplicate. The AIEC strain LF82,
and non-AIEC E. coli strain, K12, were used as controls.
To be considered AIEC, strains were required to adhere to
undifferentiated I-407 epithelial cells with an adhesion index of
one or more bacteria per cell; invade intestine-407 cells with an
invasion index greater than 0.1% of the original inoculum; and
survive and replicate within THP-1 macrophages with a survival
index of 100% or greater at 24 h relative to the number of
intracellular bacteria at 1 h post infection.9
ELISA
The amount of TNF-α, interleukin (IL) 6, IL-8 and IL-10
released into the THP-1 cell culture supernatant was determined
by ELISA (R&D Systems). Cytokine concentrations were
assessed according to the manufacturer’s instructions. All experi-
ments were done in triplicate.
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Unsupervised iterative clustering
An unsupervised iterative clustering analysis ( JMP V11, SAS
Institute) was performed to determine whether or not AIEC
strains clustered. This analysis does not use a priori knowledge
of the AIEC status of strains, but uses the raw values from the
phenotypical assays (adherence/invasion and intracellular repli-
cation) to group the isolates.
Genome sequencing and analysis
Genomic DNA was extracted from LB culture broths using
Qiagen genomic kits, and quantiﬁed using a Qubit ﬂuorescence
assay (Invitrogen). All 41 strains were subjected to whole-
genome sequencing using either an Illumina HiSeq 2000 plat-
form in a 100 bp paired-end format, a Roche GS FLX 454
sequencer or a MiSeq platform (see online supplementary
material). Assembly of the sequences was done in CLC
Workbench using global mapping, and the draft genomes
aligned in Mauve37 and annotated in GenoScope (http://www.
genoscope.cns.fr). Clustering of proteins into groups of homolo-
gous sequences was done using CD-HIT with a cut-off of 80%
amino acid identity. A binary matrix was created to indicate the
presence of protein clusters within strains. This matrix was stat-
istically compared using the R (V.3.2.0) data analysis software
(https://www.r-project.org), to determine the number of genes
per strain; to plot histograms based on gene counts; to deter-
mine whether or not there were genes unique to/more frequent
in AIEC strains compared with non-AIEC strains; and to iden-
tify genes unique to strains with high levels of invasiveness or
replication that did not meet the AIEC criteria. The MicroScope
Gene Phyloproﬁle tool38 within Genoscope (http://www.
genoscope.cns.fr) was used to conﬁrm the ﬁndings of the latter
analyses involving unique genes/gene frequencies using the fol-
lowing homology constraints: minimal alignment coverage of
0.8; sequence identity of 30%; and, bidirectional best hit. We
used MicroScope to determine the presence/absence of genes
identiﬁed in previous studies as being important for phenotyp-
ical characteristics of LF82 (rpoE,39 htrA,40 dsbA,41 hfq,42
ﬁmH,28 lpfA/gipA43–45) or AIEC/IBD-associated E. coli (vgrG,
hcp, vasD, vasG, impL, impK (Type VI secretion system genes),
vat, insA, insB,30 afaC,45 and clb (pks island),46 pduC,29 K1,
kpsmTII, fyuA, ibeA.17 The nucleotide sequence of each of these
genes was also used for phylogenetic analyses. MEGAV.647 was
used to align the sequences and generate phylogenetic trees.
Determining base composition differences in genes
Harvest software suite48 was used to build a core-genome single
nucleotide polymorphism-based tree from the assembled
genomes. From the Mauve alignment ﬁle, nucleotide base fre-
quency differences between AIEC and non-AIEC strains in the
core genome were examined over 300 bp windows and quanti-
ﬁed using the G-statistic. The base frequencies within each
window were compared between AIEC and non-AIEC strains,
as well as AIEC-ST95 strains and non-AIEC-ST95 strains. Gene
sequences with meaningful different base compositions, that is,
G-statistic values well above ‘background’ levels in AIEC com-
pared with non-AIEC strains, and AIEC-ST95 strains compared
with non-AIEC-ST95 strains (see online supplementary mater-
ial), were extracted from MicroScope using the ‘Search/Export’
and ‘Search by Keywords’ functions. The gene sequences were
saved in fasta ﬁle format and imported into MEGA V.6.47
Phylogenetic trees were constructed to determine whether or
not the AIEC or AIEC-ST95 gene sequences clustered together
when compared with non-AIEC and non-AIEC-ST95 gene
sequences, respectively.
Clustered regularly interspaced palindromic repeat analysis
Bacteria insert short sequences (‘spacers’), which they acquire
from invading viruses, into clustered regularly interspaced palin-
dromic repeat (CRISPR) loci to generate immunological
memory.49 We used the CRISPRFinder web tool50 (http://crispr.
u-psud.fr/Server/) to identify CRISPRs in AIEC-ST95 and
non-AIEC-ST95 strains, to determine whether or not particular
CRISPRs were associated with the AIEC phenotype.
RESULTS
Strain characteristics and phenotypical assays
Of the 41 B2 isolates, 11 met the criteria for AIEC, including
the AIEC strain, LF82 (ﬁgure 1). Table 1 outlines the strain
characteristics, including: serotype, ST, ability to adhere to and
to invade epithelial cells, ability to survive and replicate within
macrophages, and afﬁliation to the AIEC pathovar based on
phenotypical tests. Further information on strains, including raw
values for all three phenotyping replicates and average log10
values for the adhesion, invasion and survival/replication assays,
are provided in the online supplementary material.
The invasion level of the reference strain LF82 was 15.87%
±3.3%, for the laboratory K12 strain (laboratory strain) it was
0.06%±0.00% and for the commensal strain ED1a it was
0.05%±0.01% of the original inoculum (table 1). For the
remaining 39 B2 isolates, 13 (33%) were considered invasive
(isolated from patients with CD (n=3), patients with UC (n=3)
and patients without IBD (n=7)), with invasion levels ranging
from 0.10% to 1.89% (table 1).
As previously demonstrated,51 strain ED1a was killed by
THP-1 macrophages, demonstrating efﬁcient bactericidal activity
of the cell lines (table 1). As expected, strain K12 was also
killed, and strain LF82 resisted macrophage killing (table 1). Of
the strains 31/39 (79%) were able to resist macrophage killing
and replicate within macrophages, but only 10 of these strains
(25%) were also invasive, and therefore AIEC (table 1).
Proinﬂammatory cytokine production (TNF-α, IL-6, IL-8 and
IL-10) by infected THP-1 macrophages did not differ with the
Figure 1 A plot of invasion (log10 bacterial cells) on the x axis,
versus intracellular replication (log10 bacterial cells) on the y axis,
showing that the majority of strains in the study can replicate
intracellularly in vitro, at the level required to be considered
adherent-invasive Escherichia coli (AIEC) (horizontal yellow bar). Fewer
strains meet the AIEC invasion index (vertical yellow bar), but cannot
replicate intracellularly. To be considered AIEC, strains are required to
both invade and replicate intracellularly at the deﬁned levels. AIEC
strains are denoted by red dots, non-AIEC strains by blue triangles.
I-407 intestinal cell line was used for the adherence/invasion assays,
THP-1 macrophages for the survival/replication assays.
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AIEC phenotype of a strain (analysis of variance: TNF-α,
P> F=0.88; IL-6, P> F=0.99). IL-10 production correlated
positively with the invasiveness of the strain.
Unsupervised clustering analysis conﬁrms AIEC phenotype
An unsupervised clustering analysis, based on the raw values
from the adhesion/invasion assays, performed using I-407 epi-
thelial cells, and survival/replication assays, using THP-1 macro-
phages, shows that AIEC and non-AIEC strains cluster in two
distinct groups (ﬁgure 2), suggesting that these functions
commonly coexist in a speciﬁc isolate. Strain LF82 is more
similar to the AIEC strains than non-AIEC strains, but is an
outlier. The one non-AIEC strain in the AIEC cluster (strain
H020) demonstrated high levels of intracellular replication but
was on the borderline for cellular invasion (0.08%).
Phylogenetic distribution and serotyping
The genomes in this study were a typical size for E. coli, ranging
from 4.4 Mb to 5.4 Mb, and had an average 56×read depth (see
online supplementary material). The core-genome phylogenetic
Table 1 Characteristics and adherent-invasive Escherichia coli (AIEC) phenotype data for the B2 phylogroup E. coli strains used in the study
Strain Serotype Sequence type (ST)* Phenotype† Adhesion‡ Invasion§ Replication¶
12-1-TI12 O6: H31 127 AIEC 3.81±2.03 0.37±0.11 310.60±53.48
12-2-TI13 O6: H31 127 Non-AIEC 5.61±2.31 0.72±0.13 50.24±24.33
18-3 TI5 O25:H1 73 Non AIEC 0.25±0.10 0.04±0.01 179.30±76.61
18-4 TI12 O25:H1 73 Non AIEC 0.48±0.26 0.04±0.02 143.09±25.45
33-1-TI5 O16:H5 131 AIEC 6.68±2.28 0.10±0.03 867.09±77.11
36-1-TI13 O83:H4 429 Non AIEC 0.39±0.17 0.01±0.00 402.45±86.68
39-2-TI18 ** : ** 95 Non AIEC 0.07±0.03 0.01±0.00 1241.09±597.43
41-2-TI13 O17/O77:H41 720 Non AIEC 0.68±0.20 0.03±0.01 410.29±85.78
46-1-TI2 O1:H7 95 Non AIEC 0.20±0.06 0.01±0.01 707.98±358.64
52-1-TI3 O18:H7 95 AIEC 34.26±9.89 1.50±0.15 934.28±250.38
52-2-TI10 O75:H5 550 Non AIEC 0.11±0.08 0.01±0.00 153.11±31.56
54-1-TI6 O110:H27 1919 Non AIEC 9.30±5.13 0.07±0.03 408.36±65.09
55-1-AU4 O25:H4 131 Non AIEC 0.11±0.04 0.03±0.02 162.92±82.29
55-1-TI19 O25:H4 131 Non AIEC 0.05±0.05 0.03±0.01 325.74±164.91
57-3-TI5 O75:H5 537 AIEC 2.73±1.07 0.14±0.03 723.55±65.60
60-1-TI1 O75:H7 80 AIEC 7.08±1.35 0.13±0.06 333.25±107.54
61-1-TI1 O18:H7 95 AIEC 54.63±16.65 1.89±0.70 869.90±211.49
62-2-TI6 O1:H7 95 Non AIEC 1.24±0.33 0.14±0.02 90.74±35.52
63-1-TI1 O50O2:H18 963 Non AIEC 1.43±0.63 0.03±0.00 158.22±42.48
69-1 AU1 O46:H31 569 Non AIEC 0.66±0.15 0.07±0.03 79.02±12.65
69-1-TI1 O46:H31 569 Non-AIEC 0.60±0.13 0.10±0.03 91.37±30.65
70-2-TI12 O46:H31 569 Non-AIEC 1.22±0.58 0.06±0.01 45.49±5.68
72-6-Ti12 O46:H31 569 Non-AIEC 1.05±0.06 0.03±0.00 73.82±17.73
CD 1IM 3 O83:H6 2622 Non-AIEC 3.47±0.27 0.02±0.00 1163.70±203.59
CD 34 LN O1:H7 95 Non-AIEC 0.14±0.06 0.02±0.00 458.485±105.69
CD 62 LN O2:H4 95 AIEC 4.68±2.07 0.33±0.06 1686.33±307.68
H001 O8:H10 681 Non-AIEC 1.19±0.02 0.02±0.00 708.12±55.32
H020 O22:H1 73 Non-AIEC 1.33±0.07 0.08±0.04 1009.20±137.15
H223 O2:H6 141 AIEC 9.03±2.55 0.46±0.23 435.23±108.95
H252 O1:H7 95 Non-AIEC 3.47±0.20 0.09±0.04 74.23±30.72
H263 O2:H7 95 Non-AIEC 0.30±0.03 0.01±0.00 398.51±93.69
H296 O2:H7 95 Non-AIEC 0.45±0.04 0.00±0.00 792.33±78.74
H305 O18:H7 95 AIEC 27.52±6.10 0.63±0.24 730.65±68.44
H397 O1:H7 95 Non-AIEC 0.42±0.09 0.01±0.00 245.22±50.18
H413 O18:H7 95 Non-AIEC 0.91±0.05 0.02±0.00 717.92±411.86
H461 O18:H7 95 Non-AIEC 0.40±0.07 0.01±0.00 73.60±19.38
H504 O18ac:H7 95 AIEC 3.28±1.78 0.28±0.03 330.81±80.68
H588 ** :H5 126 Non-AIEC 3.38±1.39 0.04±0.00 1141.51±65.45
H660 O1:H7 95 Non-AIEC 0.52±0.16 0.01±0.00 701.56±145.06
ED1a O81:H27 452 Non-AIEC 0.25±0.07 0.05±0.01 68.34±30.95
LF82 O83:H1 135 AIEC 62.83±5.08 12.23±2.01 227.81±61.37
K-12 OR:H48 10 Non-AIEC 1.43±0.40 0.02±0.00 22.49±4.34
Results for adhesion, invasion and replication assays, data are means±SEM of independent experiments.
*Sequence type (ST) is based on the multilocus sequence type (MLST) scheme of Wirth et al.23
†Determination of E. coli strains as belonging to the AIEC pathovar was performed using the following criteria: (1) the ability to adhere to I-407 epithelial cells with an adhesion index
equal or superior to 1 bacteria per cell, (2) the ability of the bacteria to invade I-407 with an invasion index equal or superior to 0.1% of the original inoculum, (3) the ability to survive
and to replicate within THP-1 macrophages.
‡Mean number of bacteria per I-407 cell after 3 h of incubation.
§Mean percentage of the original inoculum after 1 h gentamicin treatment of infected I-407 cells.
¶Percentage of intracellular bacteria at 24 h post infection relative to the number after 1 h gentamicin treatment, defined as 100%.
**No O-antigen processing genes and/or H-antigen flagellin genes detected using the SeroType Finder tool (http://www.genomicepidemiology.org).
LN, lymph node.
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tree presented in ﬁgure 3 shows that the 11 AIEC isolates have
diverse B2 phylogenetic backgrounds, as they are dispersed
among the 31 non-AIEC strains, and represented across seven
B2 lineages (ST131, ST127, ST80, ST537, ST135, ST141,
ST95). This is despite strain selection being biased towards the
ST95 lineage. The AIEC strains also represent diverse serotypes
(O16:H5, O6:H31, O75:H7, O75:H5, O83:H1, O2:H6, O2:
H4, O2:H7, O18:H7 and O18ac:H7). Of the ST95 strains, four
of six strains with the O18:H7 serotype are AIEC (table 1).
Comparative genome analyses
The AIEC strains did not harbour any unique genes when com-
pared with the non-AIEC strains, nor were there any gene(s)
present in the majority of AIEC strains, but absent in non-AIEC
strains. There were no genes present in all non-AIEC strains that
were absent from all AIEC strains. There were no genes unique
to strains with a replication index (using THP-1 macrophage
cell line) that met the AIEC criteria, but a level of adhesion/
invasion (using I-407 cell line) that did not; strains with an
adherence/invasion index that met the criteria for AIEC, but a
level of replication that did not; strains with a high capability to
replicate within macrophages, having a replication index of
>700, or >1000 (where the percentage of the number of intra-
cellular bacteria at 24 h post infection relative to that obtained
at 1 h post infection is deﬁned as 100%), regardless of their
adhesion/invasion index; or strains from patients with CD com-
pared with controls.
Two of the 41 strains, 12–1 ti12 and 12–2 ti13, were isolated
from the same patient but displayed different AIEC phenotypes.
The genomes of these two strains differed by 151 genes,
however none of the genes unique to the AIEC strain, 12–1
ti12, were present in all, or the majority of, the other AIEC
strains, and none of the genes unique to strain 12–2 ti13 were
absent from all, or the majority of, other AIEC strains. The vari-
able gene content of these two strains is presented in the online
supplementary material.
We conducted presence/absence and phylogenetic analyses on
the following LF82-associated genes: rpoE;39 htrA (also known
as degP and ptd);40 dsbA,41 hfq,42 and AIEC/IBD-associated
E. coli genes: pduC29 (propanediol utilisation), fyuA, ibeA, K1,
kpsmTII,17 vgrG, hcp, vasD, vasG, impL, impK (type VI secretion
system genes), and vat, insA, insB,30 ﬁmH,28 afaC45 and clb (pks
island),46and the combination of gipA and lpfA,43 or lpfA
alone.44 45 Nine of the 41 strains harboured the afaC gene
(H504, H305, H020, H296, 61–1 ti1, 52–2 ti10, 52–1 ti3, 18–4
ti12, 18–3 ti5), 4 of which were AIEC (36% of all AIEC strains),
belonged to ST95 and had an O18:H7 serotype. The only gene
that was detected in all AIEC strains was ﬁmH, however this gene
is present in most B2 phylogroup E. coli strains. Differences in
the base composition of all the above-mentioned genes were
largely driven by ST, thereby phylogenetic in nature, not the
AIEC status of the strains. The most common ﬁnding was that
ST95 strains had a different variant (base composition) of a gene
than other STs. One exception to this was ﬁmH, as the ﬁmH
variant of ST95 strains with an O18:H7 serotype was different
to that of other ST95 strains with a different serotype.
Differences in base composition of genes
We identiﬁed numerous genes where the base composition in
AIEC strains differed from that in non-AIEC strains over a
Figure 2 Unsupervised iterative clustering analysis showing that
adherent-invasive Escherichia coli (AIEC) strains (dots), and non-AIEC
strains (triangles) naturally group together based on the log10 values
from the adherence/invasion (I-407 cell line), and survival/replication
(THP-1 macrophage cell line) assays. Strain LF82, shown at the right of
the graph, is more similar to AIEC strains than non-AIEC strains, but is
an outlier. The axes represent Principal 1, Prin 1, and Principal 2, Prin
2, of the analysis.
Figure 3 Core-genome phylogenetic tree for all 41 of the B2
phylogroup strains of Escherichia coli used in the study, showing the
position of the 11 adherent-invasive E. coli (AIEC) strains (red). The
AIEC strains have diverse genetic backgrounds and are spread
throughout the tree. An orange ‘Crohn’s disease (CD)’ indicates strains
isolated from patients with CD, a blue ‘UC’ strain from patients with
UC and a green ‘N’ strain from patients without IBD. The sequence
type of each strain is indicated on the right, and follows the multilocus
sequence type (MLST) classiﬁcation scheme by Wirth et al. AIEC strains
display phylogenetic heterogeneity, as they are present across a large
number of STs within the B2 phylogenetic lineage.
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300 bp window. We conducted phylogenetic analyses on the fol-
lowing genes, which met inclusion criteria (G-statistic >0.05,
MI> 0.01, see online supplementary material): nagE, ompN,
ompF, ugd, dusA, yghJ, fkpA, btuB, prp and yehH. When the
AIEC-ST95 and non-AIEC-ST95 strains were compared, the fol-
lowing genes were identiﬁed: yjjM, yjjN, galF, gnd, hchA and
wcaK, and analysed phylogenetically. For each of these genes,
either there was no clustering of the AIEC strains, or strains
clustered according to lineage (based on the entire core
genome), irrespective of their AIEC status. The online supple-
mentary material outlines all genes shown to have meaningfully
different base frequencies when AIEC and non-AIEC, and,
AIEC-ST95 and non-AIEC-ST95 strains were compared.
CRISPR analyses
Among the 16 ST95 strains tested, we identiﬁed 23 conﬁrmed
CRISPRs and 26 possible CRISPRs, with an average of 2.4 con-
ﬁrmed CRISPRs (range: 2–5) and 3.3 possible CRISPRs (range: 0–
8) per strain. AIEC-ST95 strains did not harbour speciﬁc
CRISPRs, nor was the frequency of CRISPRs, or possible
CRISPRs, signiﬁcantly different to that of non-AIEC-ST95 strains.
CRISPR analysis of closely related strains 12–1 (AIEC) and
12–2 ti13 (non-AIEC), from the same patient, and 55–1 AU4
and 55–1 ti19 from another patient, demonstrated different
CRISPR proﬁles. Strain 12–1 ti12 possessed four possible CRISPRs,
whereas strain 12–2 ti13 possessed ﬁve possible CRISPRs, none
of which were found in strain 12–1 ti12 (see online supplemen-
tary material). Strain 55–1 AU4 and 55–1 ti19 both had three
possible CRISPRs, they shared two of these and had one unique
CRISPR each.
DISCUSSION
One of the difﬁculties associated with E. coli comparative gen-
omics is the among-strain variability in gene content.33 An E. coli
genome typically consists of about 4500 genes, but less than half
of these are core genes present in all strains. The balance of genes
is drawn from a pool of more than 14 000 unique accessory
genes. In an attempt to minimise the among-strain differences in
gene content, we chose to work preferentially with strains
belonging to a single phylogroup (B2), and to further reﬁne our
focus, strains that were ST95. We selected strains that were iso-
lated from a single gut region, to account for any possible niche
differences. Despite this choice of strains, we did not identify a
single or multiple genes of the variable genome associated with
all, or the majority of, our Australian AIEC isolates.
AIEC employ different sets or variants of genes, to overcome
mechanical forces in the gut, mucosal defenses, and subvert
antimicrobial macrophage pathways. We show that no single
gene is associated with the ability of the strains to invade epithe-
lial cells, or to survive/replicate within macrophages. UPEC also
overcome numerous defences in order to adhere to and invade
the urinary tract, and as we have shown for AIEC, there is no
speciﬁc gene associated with UPEC. While some factors, such as
type 1 pili are important for UPEC to be able to establish an
infection, these factors are not restricted to UPEC. E. coli have
a range of mechanisms that enable them to invade epithelial
cells and replicate in macrophages; these factors are not exclu-
sive to AIEC. Given the multiple processes facilitating invasion
and replication, and source of origin (GI lumen) of AIEC and
UPEC, it is likely that these two pathovars overlap.
The Intestine-407 (I-407) cell line was used in this study to
evaluate adhesion and invasion abilities of E. coli strains to epi-
thelial cells, as in the original description of the AIEC patho-
var.9 15 This cell line actually resulted from hela cell (HeLa)
contamination and is of cervical carcinoma origin, not embry-
onic intestinal origin as originally thought,52 but is still used as a
model for measuring the ability of intestinal bacteria to adhere
to and to invade epithelial cells.45 53 Other studies of AIEC
used cancerous cell lines such as Caco-216 and HT-29 cell
lines,11 derived from colorectal carcinomas, and the HEp-2 cell
line,17 which is also the result of HeLa contamination. It is not
clear how applicable these cell lines are to CD pathogenesis,
given their non-intestinal, transformed or cancerous origin.
It is plausible, especially given the lack of empirical evidence
demonstrating the presence of AIEC within human epithelial
cells, that AIEC use other routes to invade intestinal mucosa,
for example by translocation across M cells lining the
follicle-associated epithelia. Many other pathogens exploit this
route of entry, including enteropathogenic E. coli and enterohae-
morrhagic E. coli to colonise the intestinal epithelium.
Chassaing et al54 showed that some AIEC interact with human
and mouse Peyer’s patches through the expression of type 1 pili
and LPF. AIEC type 1 pili-mediated interaction with CEACAM6
could also disrupt barrier integrity giving bacteria access to the
subepithelial compartment.55 In addition, the ability to adhere
to and invade intestinal epithelial cells may not be required in
the presence of mucosal ulceration, and may not be relevant to
the pathogenesis of CD.
The ability of E. coli to adhere to and invade different cell
lines depends both on bacterial factors, such as the expression
of various adhesion or invasion factors, and the speciﬁc cell line
used. Martin et al11 showed that colonic mucosa-associated E.
coli strains from CD and colon cancer differed in their ability to
invade two epithelial cell lines: I-407 and HT29. The HT29
cell line is of human colon adenocarcinoma origin, and the vast
majority of strains adhered poorly to these cells compared with
I-407 cells: 74% of strains invaded I-407 cells, but only 9% of
strains invaded HT29 cells. AIEC strain LF82 was a notable
exception, invading both cell lines at a similar rate. Boudeau
et al15 found that strains LF82 and K12 displayed consistent
levels of invasion across three different cell lines (I-407, Caco-2
and HCT-8), but that enteroinvasive E. coli reference strain
E12860/0, which invades colonic epithelial cells in vivo, showed
inconsistent levels of invasion. They invaded Caco-2 cells at a
very low level, I-407 cells at an intermediate level similar to
LF82 and HCT-8 cells at a much higher rate than any strain
tested, including LF82.
There are also strain-dependent differences in intramacroph-
age survival and replication of E. coli. Bokil et al56 found that
clinical UPEC isolates performed differently in murine and
human macrophages. We used the human THP-1 myelomonocy-
tic cell line that displays macrophage-like activity. It is not
known if the more widely used murine J774 reticulosarcoma
cell line results in the same AIEC designation. A cross-validation
study is underway to determine whether or not different cell
lines and scoring criteria result in the same AIEC designation;
the outcome may result in a standardised approach to AIEC
phenotyping. These studies may help in terms of deﬁning the
phenotype, AIEC, however we cannot be certain that the in
vitro behaviour of strains reﬂects their in vivo behaviour.
We found that 79% of our B2 phylogroup E. coli strains, irre-
spective of AIEC status, could survive and replicate within
macrophages. Subramanian et al57 also observed considerable
overlap between the ability of CD and control isolates to repli-
cate within macrophages, and Raisch et al51 showed that 84%
of colon cancer-associated B2 E. coli strains can survive and rep-
licate within THP-1 macrophages. UPEC are also capable of
intramacrophage replication.56 A recent study showed that E.
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coli strains isolated from patients with CD, irrespective of their
adherent, invasive phenotype, survived longer in monocyte-
derived macrophages isolated from patients with CD than con-
trols, demonstrating that host immunodeﬁciency is an important
factor allowing E. coli to persist.58 These ﬁndings implicate a
broader set of E. coli in CD pathogenesis: those that are capable
of intramacrophage survival and replication. The use of macro-
phages isolated from patients with CD, and the isolation of
strains from more relevant tissues, such as aphthous ulcers and
lymph nodes, may represent a better model to study
host-microbe interactions in CD. In such experiments, host
genetic susceptibility factors, and particularly those related to
detection and intracellular control of invaders (polymorphisms
in pattern recognition receptor (PRRs) and autophagy-related
genes) should be taken into account, as they will inﬂuence the
intracellular behaviour of bacteria.59
One of our AIEC strains, isolated from a lymph node of a
CD bowel resection, showed the highest level of replication of
all strains. Another non-AIEC strain, isolated from a lymph
node of a different patient with CD, was better at replicating
intracellularly than LF82. Intracellular replication may be more
important than a strain’s ability to adhere/invade epithelial cells,
because host mutations in genes involved in macrophage func-
tion likely lead to increased intramacrophage survival. It is
plausible that defective macrophages serve as bacterial reser-
voirs, like the quiescent intracellular reservoirs and intracellular
bacterial communities characteristic of UPEC.
In conclusion, we were unable to identify a speciﬁc molecular
property of the AIEC phenotype by comparing genomes, gene
variants and base composition differences of genetically similar
AIEC and non-AIEC strains. Studying the interactions of a
broader range of E. coli and their interactions, for example,
with monocyte-derived macrophages isolated from patients with
CD, may provide further insights into additional or alternative
pathogenic mechanisms.
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